SOX2 and neoplasm: Whilst conditional Sox2 deletion did not affect tumorigenesis or tumour growth in the K14:BRAFV600E-SOX2fl/fl model, it significantly delayed tumour onset and tumour growth in the Ivl:BRAFV600E-SOX2fl/fl model (Fig. 6b–e).